The Inside Knowledge: Get the Facts About Gynecologic Cancer campaign raises awareness of the five main types of gynecologic cancer: cervical, ovarian, uterine, vaginal, and vulvar. It encourages women to pay attention to their bodies and know what is normal for them so they can recognize the warning signs of gynecologic cancers and seek medical care. This report provides an overview of the development of this national campaign.
Introduction
Each year, about 80,900 women in the United States are diagnosed with and nearly 28,000 women die from gynecologic cancers. 1 A recent report estimates approximately 1 million American women who had been diagnosed with a gynecologic cancer were alive as of January 1, 2007. 2 The five main types of gynecologic cancer are cervical, ovarian, uterine, vaginal, and vulvar.
In 2007, the most recent year for which data are available, more than 12,000 women in the United States were diagnosed with cervical cancer, and about 4,000 died from it. 1 Cervical cancer is the easiest female cancer to prevent with regular screening tests and follow-up. It is the only gynecologic cancer for which population-based routine screening is recommended. That it is not among the top 10 most common or deadliest cancers is largely because of the widespread use of the Papanicolaou (Pap) test, which screens for precancers (cell changes on the cervix that may become cervical cancer if they are not treated appropriately), and the human papillomavirus (HPV) test, which looks for the HPV, the virus that can cause these cell changes. The HPV test may be used for screening women aged ≥30 years or at any age for women who have unclear Pap test results.
Ovarian cancer is the deadliest gynecologic malignancy. 1 Approximately 20,000 women are diagnosed with and about 15,000 women die each year from ovarian cancer. 1 Although an effective screening test for ovarian cancer does not exist, there have been several advances in treatment that have resulted in improved survival from ovarian cancer. 3 It is the eighth most common cancer among women in the United States and the fifth leading cause of cancer deaths. 1 Most ovarian cancers are sporadic in nature; however, about 10% of ovarian cancer is linked to genetic syndromes. 4, 5 Women with mutations in the BRCA1 and BRCA2 genes, and those with Lynch syndrome are at greater risk than the general population for ovarian cancer. 6 Uterine cancer is the most commonly diagnosed gynecologic cancer (fourth most common cancer in women) and is the eighth leading cause of cancer death among American women. Every year, about 41,000 women are diagnosed with and nearly 7,500 die from uterine cancer. 1 Vaginal and vulvar cancers are rare malignancies. In the United States, 1,149 women learned they had vaginal cancer, and 376 died from it, and 4,159 women were diagnosed with vulvar cancer and 865 died from it in 2007. 1 Approximately 40% of vaginal and vulvar cancers have been attributed to HPV. 7 The Inside Knowledge: Get the Facts About Gynecologic Cancer campaign educates women and healthcare providers about the signs, symptoms, risk factors, and prevention strategies related to cervical, ovarian, uterine, vaginal, and vulvar cancers. Developed and implemented by the Centers for Disease Control and Prevention (CDC), in collaboration with the U.S. Department of Health and Human Services' (HHS) Office on Women's Health, Inside Knowledge supports the Gynecologic Cancer Education and Awareness Act of 2005, or Johanna's Law (www.cdc.gov/cancer/gynecologic/pdf/JohannasLaw.pdf), which was signed into law on January 12, 2007. Johanna's Law authorizes CDC to carry out a national campaign to increase women's and healthcare providers' awareness and knowledge of gynecologic cancers; develop, produce, and maintain a supply of written materials that provide information to the public on gynecologic cancers; distribute materials to the public on request; develop and place public service announcements (PSAs); and call attention to early warning signs and risk factors based on the best available medical information.
Campaign Challenges and Opportunities
A lack of recommended population-based screening for all gynecologic cancers except cervical cancer and the wide range and vague nature of symptoms associated with most gynecologic cancers present distinct challenges for a national awareness campaign. Another significant challenge is that each gynecologic cancer is unique in terms of signs, symptoms, risk factors, and prevention strategies.
For cervical cancer, the main messages of the Inside Knowledge campaign include an action step that most women can take relatively easily: get screened as recommended. For ovarian and other gynecologic cancers, however, key campaign messages center (by necessity) on awareness of risk factors and symptom recognition to promote early detection, timely treatment, and improved health outcomes. The absence of a clear message promoting screening for ovarian, uterine, vaginal, and vulvar cancers can be frustrating both for women who await the development of effective screening strategies and for the medical and public health communities that lack evidence-based tools to prevent and detect early disease. 8 All these factors underscore an important need to educate and communicate with women and healthcare providers about gynecologic cancer.
Additional challenges center on what many studies have shown to be common misunderstandings and misconceptions about the Pap test and pelvic examination. [9] [10] [11] [12] Previous studies have reported that women do not know the purpose of a Pap test and believe that it screens for multiple gynecologic cancers, sexually transmitted diseases (STDs), and other conditions. [8] [9] [10] [11] [12] [13] Recent discussions among healthcare providers have also questioned the need and purpose of the pelvic examination. 14, 15 Knowledge among women about symptoms related to gynecologic cancers also is lacking. 8, 16 Symptom recognition is important for both women and their healthcare providers, particularly in the absence of recommended screening options, especially in the case of ovarian cancer. 17 Without understanding what symptoms are associated with ovarian cancers, for example, women may discount those that are vague and unspecific, and they may go unchecked for some time until symptoms become so persistent or alarming that a woman seeks medical attention. 18, 19 Likewise, educating healthcare providers to recognize symptoms that may be potential signs of ovarian cancer may lead to earlier detection at a more treatable stage. 20, 21 Patients with certain gynecologic and gastrointestinal symptoms 22 may benefit substantially from education and awareness or by more active surveillance and diagnostic workup.
Although these challenges exist, they have not been insurmountable, as some common themes can be extracted and applied. For instance, cervical, vaginal, and vulvar cancers have a common thread in their relation to HPV infection, and ovarian and uterine cancers are similar in their age of onset (mainly occurring in postmenopausal women) as well as their possible genetic connection. 6 Therefore, targeted information to these populations of women is of great value for multiple gynecologic cancers. Education about the gynecologic organ system and functions overall, as well as recommendation of treatment by gynecologic oncologists who more often adhere to guidelines-based care, are two examples of crosscutting themes that can be applied to every cancer included in the Inside Knowledge campaign.
Concurrently, a few months after Johanna's Law was enacted, CDC convened a panel of gynecologic cancer experts in San Diego, CA, to discuss the state of the science and potential education and awareness messages for gynecologic cancers. The panel comprised gynecologic oncologists, gynecologists, pediatricians, nurses, other medical practitioners, health and behavioral scientists, and representatives of nonprofit and advocacy organizations committed to raising awareness of gynecologic cancers.
The general framework and development of Inside Knowledge messages and materials were based initially on what was learned in the literature review and during the expert panel meeting, where information gaps were identified, and consensus was reached on main messages and strategies to raise awareness about gynecologic cancer. Campaign messages were further refined based on focus group research conducted across the United States by CDC to learn more about women's gynecologic cancer knowledge, attitudes, beliefs, and behaviors. In 2009, CDC conducted 48 focus groups in English and Spanish with a total of 408 women (262 English speakers and 146 Spanish speakers) aged 40-60 years in New York City, Atlanta, Miami, Los Angeles, Houston, Chicago, and Las Vegas. In addition to formative research conducted in the focus groups, the groups also served to test creative approaches and strategies to ensure that campaign materials delivered intended messages in the most effective ways.
The main campaign messages are:
• There are several types of gynecologic cancer.
• When gynecologic cancers are found early, treatment is most effective.
• Pay attention to your body and know what is normal for you. Gynecologic cancers have warning signs.
• If you have vaginal bleeding that is unusual for you because of when it occurs or how heavy it is, see a doctor right away.
• If you notice any other unexplained signs or symptoms that last for 2 weeks or longer, see a doctor.
• Get a Pap test regularly to screen for cervical cancer. (The Pap test does not screen for ovarian, uterine, vaginal, or vulvar cancers. Even if you have a Pap test regularly, see your doctor if you notice any signs or symptoms that are not normal for you.)
• Get the HPV vaccine if you are 11-26 years old.
• If you are diagnosed with a gynecologic cancer, see a gynecologic oncologist, a doctor who is trained to treat cancers of the female reproductive system.
Additional Research to Inform the Campaign
In addition to focus groups with consumers as described, Inside Knowledge also conducted formative research with healthcare providers in 2011, using a combination of in-person and telephone focus groups. There were 24 in-person groups, with 6 groups each in Las Vegas, Philadelphia, Atlanta, and Chicago, as well as 6 telephone groups comprising participants from rural, suburban, and urban areas around the country. Of the 30 groups held (in person and via telephone), 10 included gynecologists, 10 were with primary care physicians, and the remaining 10 were with nurse practitioners. Data analysis from these groups is ongoing, with results informing future campaign development. women respondents had heard of the Pap test; however, this proportion was lower in women aged 18-34 years and among those who had lower levels of education and income. 13 Over 80% of the respondents knew the Pap test was used to screen for cervical cancer; however, substantial percentages of women (35%-45%) erroneously thought the Pap test was also used to screen for other gynecologic cancers, such as ovarian and uterine cancer, and for STDs. 13 Misunderstandings about the purpose of the Pap test were highly prevalent even among women with relevant health experiences, such as those with a history of abnormal Pap test results or a previous cervical cancer diagnosis. Only 17.9% of women respondents correctly identified the Pap test as being a screen for cervical cancer exclusively. 13 These results indicate widespread misconceptions about the purpose of Pap testing. Another study resulting from the HealthStyles data analysis investigated the knowledge and behaviors of women about the cancer antigen-125 (CA-125) blood test and ovarian cancer. This study showed that about 25% of women reported having heard of the CA-125, with about 10% of women reporting having previously received a CA-125 blood test. 24 Characteristics of women who had not heard of or had the CA-125 blood test were similar to those who had, with the exception that those who had heard of it/had it were more often older and perimenopausal or postmenopausal. 24 Concern for getting ovarian cancer did not differ significantly among women who heard of/had the CA-125 test compared to those who had not heard of or had it. 24 A third analysis from the same survey data examined self-reported intent to seek care for symptoms associated with ovarian cancer. The results showed that gynecologic symptoms (such as post-menopausal bleeding) prompted more intention to seek care than those that would be considered less gynecologic in nature but are, in fact, associated with ovarian cancer (e.g., feeling full after eating a small amount). 16 For most symptoms, postmenopausal women and those concerned about getting ovarian cancer more often responded that they intended to seek care than did younger women and those without such concern. 16 All these studies and data analyses-several of which are continuing-will further help Inside Knowledge campaign planners develop messages and educate women about gynecologic cancer symptoms, including those that are nongynecologic in nature.
DocStyles is an annual survey of physicians who practice in the United States and treat at least 10 patients a week and have been in practice for at least 3 years. One thousand primary care physicians (510 family/general practitioners and 490 internists) and 250 obstetrician/ gynecologists responded to our DocStyles questions on HPV vaccination, CA-125, transvaginal ultrasound, and pelvic examination knowledge and beliefs. Analyses from the DocStyles survey indicated that almost 50% of primary care physicians responded that CA-125 alone or CA-125 and transvaginal ultrasound were effective ovarian cancer screens in the asymptomatic, average-risk population, 24 a belief that is inconsistent with screening guidelines for ovarian cancer. Obstetrician/gynecologists more often had guidelinesconsistent responses, with a little over half (56%) responding that neither CA-125 nor transvaginal ultrasound was an effective screen in the asymptomatic, average-risk population, compared to internists and general or family practitioners. The large percentage of physicians whose responses were inconsistent with current screening recommendations underscores the need for more education about both the current lack of a screening test for ovarian cancer and the potential harms of the CA-125 blood test.
Analyses of data from the 2008 and 2009 surveys are ongoing. In 2009, the Inside Knowledge campaign commissioned similar questions in the HealthStyles and DocStyles surveys, and questions about primary care physician referral patterns to gynecologic oncologists for ovarian cancer care also were asked. These questions probe referrals to and treatment by gynecologic oncologists, as evidence has shown that such referrals, particularly for women with ovarian cancer, result in better survival rates. 25 Analyses of these questions can potentially reveal barriers to receipt of appropriate care, and suggest further avenues for targeted education through the campaign.
Patient and Healthcare Provider Materials Development
Inside Knowledge educational materials are developed in consultation with CDC scientists and external gynecologic cancer experts to ensure scientific and medical accuracy. All materials undergo multiple rounds of rigorous review for technical content and consumer appropriateness. The campaign has developed a robust suite of patient education resources, several of which are available in English and Spanish (Fig. 1) .
Materials created to date include fact sheets on each of the five main gynecologic cancers, a comprehensive gynecologic cancer brochure, print and broadcast PSAs, posters, out-ofhome advertising (such as airport and other transit and shopping mall dioramas), and a gynecologic cancer symptoms diary (Fig. 2) . All patient education materials are available for preview or download from the campaign's website, www.cdc.gov/cancer/knowledge. The campaign's website itself is revised and updated periodically, with new features and resources added as they become available. For example, in March 2011, a new feature, Survivor Stories, was added, along with new design elements and photos for the campaign's homepage. The campaign also employs and incorporates novel communication tools, as resources allow, to widely disseminate campaign materials. New technologies and social media channels used to date include Facebook, Twitter, podcasts, CDC Radio, CDC TV, electronic greeting cards, and CDC's YouTube Streaming Health Channel.
The patient education materials created by Inside Knowledge are designed to also be useful to healthcare providers in their communication with patients about gynecologic cancers. To that end, CDC has displayed campaign resources at a variety of healthcare provider professional meetings and presented papers and posters at professional gatherings whenever possible. Development of additional provider materials will be determined by analysis of recently completed provider formative research.
Future materials for healthcare providers likely will emphasize increasing awareness and knowledge of gynecologic cancer etiology, appropriate screening and diagnostic tests (e.g., the role of the Pap test in cervical cancer screening), genomics and cancer risk, symptom recognition, effective communication with patients about gynecologic cancers, and the importance of timely referral to gynecologic oncologists for patients diagnosed with gynecologic cancers. By developing and making such resources available, CDC hopes to increase healthcare provider knowledge of gynecologic cancer issues, which may translate to improved care for women.
Public Service Announcements Development and Dissemination
Inside Knowledge PSAs were developed after focus group research with women around the country to evaluate message salience as well as creative appeal and clarity. After launching the campaign's first PSAs in 2010, CDC developed additional TV and print PSAs, as well as other out-of-home advertising, and began releasing them in May 2011. The latest spots feature writer/performer Jenny Allen, a survivor of both uterine and ovarian cancers who wrote and performed a one-woman stage show called, "I Got Sick Then I Got Better." In Inside Knowledge PSAs, she speaks about the importance of recognizing symptoms and encourages women who notice anything unusual to: Be brave, go to the doctor, ask questions (Fig. 3a) .
The Inside Knowledge PSAs have been distributed throughout the United States to more than 1,500 English and Spanish network, cable, and local television outlets; 6,200 radio outlets; and 2,000 magazines and newspapers. Out-of-home placements (as of June 2011) include airport dioramas, posters and similar displays in shopping malls, and bus/bus shelter displays. Currently, the campaign relies on donated placements in all media.
PSA Tracking and Process Evaluation
The campaign uses several methods of tracking: monitoring website hits, publication orders, public inquiries, social media and search engine mentions, and PSA use. TV PSA use is monitored electronically, with PSAs specially encoded to con-firm when and where they are broadcast. Radio PSA use is similarly tracked through a combination of electronic monitoring and bounce-back cards from stations. Print ad use is tracked using a national media monitoring and clipping service.
Perhaps the most impressive data to date centers on television and radio PSA tracking. 
Future Directions
As funding allows, CDC will increase support for activities that will help to inform future implementation of the Inside Knowledge campaign. Evaluation plans include conducting additional process and formative research to assess the campaign's implementation, reach, and public health impact. As awareness and educational resources are disseminated, CDC intends to conduct research to evaluate the effects of the campaign overall and on women's and healthcare providers' knowledge, attitudes, and behaviors related to gynecologic cancers.
